Product NDC: | 17312-019 |
Proprietary Name: | Irritable Bowel Syndrome Therapy |
Non Proprietary Name: | ASAFETIDA - BISMUTH SUBNITRATE - BRYONIA ALBA ROOT - ACTIVATED CHARCOAL - LYCOPODIUM CLAVATUM SPORE - SODIUM CARBONATE - STRYCHNOS NUX-VOMICA SEED - VERATRUM ALBUM ROOT - |
Active Ingredient(s): | 6; 3; 6; 6; 6; 6; 6; 6 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 & nbsp; ASAFETIDA - BISMUTH SUBNITRATE - BRYONIA ALBA ROOT - ACTIVATED CHARCOAL - LYCOPODIUM CLAVATUM SPORE - SODIUM CARBONATE - STRYCHNOS NUX-VOMICA SEED - VERATRUM ALBUM ROOT - |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 17312-019 |
Labeler Name: | TRP Company |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED HOMEOPATHIC |
Start Marketing Date: | 20111201 |
Package NDC: | 17312-019-14 |
Package Description: | 1 BOTTLE in 1 PACKAGE (17312-019-14) > 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE |
NDC Code | 17312-019-14 |
Proprietary Name | Irritable Bowel Syndrome Therapy |
Package Description | 1 BOTTLE in 1 PACKAGE (17312-019-14) > 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE |
Product NDC | 17312-019 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | ASAFETIDA - BISMUTH SUBNITRATE - BRYONIA ALBA ROOT - ACTIVATED CHARCOAL - LYCOPODIUM CLAVATUM SPORE - SODIUM CARBONATE - STRYCHNOS NUX-VOMICA SEED - VERATRUM ALBUM ROOT - |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20111201 |
Marketing Category Name | UNAPPROVED HOMEOPATHIC |
Labeler Name | TRP Company |
Substance Name | ACTIVATED CHARCOAL; ASAFETIDA; BISMUTH SUBNITRATE; BRYONIA ALBA ROOT; LYCOPODIUM CLAVATUM SPORE; SODIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; VERATRUM ALBUM ROOT |
Strength Number | 6; 3; 6; 6; 6; 6; 6; 6 |
Strength Unit | [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 |
Pharmaceutical Classes |